Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serotype-specific pneumococcal conjugate vaccine effectiveness in Canadian children: an indirect cohort study using Bayesian hierarchical modeling of multisite data.

BMC infectious diseases·2026
Same author

Are hemagglutinin-only influenza vaccines as effective as conventional influenza vaccines against severe infection?

Vaccine·2026
Same author

Off-Label use of vaccines may save lives and money: lessons from the province of Quebec, Canada.

Expert review of vaccines·2025
Same author

Effectiveness of the four-component protein-based meningococcal vaccine against <i>Neisseria gonorrhoeae</i> infections: Mounting evidence and public health implications for Canada.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2025
Same author

A new approach to define the optimal immunization strategy against pneumococcal disease: the example of Canada.

Epidemiology and infection·2025
Same author

Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.

The Journal of infection·2025

Related Experiment Video

Updated: Jun 5, 2026

Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience.

Philippe De Wals1

  • 1Department of Social and Preventive Medicine, Laval University, 1050 Avenue de la Médecine, Quebec City, G1V 0A6, Canada. philippe.dewals@msp.ulaval.ca

Expert Review of Vaccines
|December 18, 2010
PubMed
Summary

Quebec

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Development of an IFN-&#947; ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Experiment Videos

Last Updated: Jun 5, 2026

Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Development of an IFN-&#947; ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Area of Science:

  • Public Health
  • Immunization Programs
  • Health Policy

Background:

  • Publicly funded immunization programs in Canada are managed provincially/territorially.
  • Quebec has focused on optimizing childhood immunization programs for acceptability, effectiveness, and cost-effectiveness over two decades.

Purpose of the Study:

  • To describe the planning, implementation, and evaluation processes of Quebec's immunization programs.
  • To identify critical success factors for these public health initiatives.

Main Methods:

  • Development of a comprehensive societal-perspective framework for evaluating new vaccines and programs.
  • Systematic stakeholder surveys and consultations to anticipate implementation challenges.
  • Dedicated budget allocation for ongoing program evaluation and monitoring.

Main Results:

  • A robust evaluation framework is utilized by the Quebec Immunization Committee to inform public health decisions.
  • High vaccine uptake rates are achieved with a streamlined schedule (15 diseases, 20 injections by age 15).
  • Program effectiveness is highly satisfactory, demonstrated by successful control of diseases like hepatitis B, meningococcal, and pneumococcal infections.

Conclusions:

  • Quebec's structured approach to immunization program planning, implementation, and evaluation yields successful public health outcomes.
  • The province demonstrates that optimized, cost-effective immunization strategies can achieve high vaccine coverage and disease prevention.